815PDA PHASE I/II TRIAL OF BNC105P WITH EVEROLIMUS IN...

Annals of Oncology 2014 / 09 Vol. 25; Iss. suppl_4

815PDA PHASE I/II TRIAL OF BNC105P WITH EVEROLIMUS IN METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS OF THE RANDOMIZED PHASE II DISRUPTOR-1 TRIAL

Pal, S., Azad, A., Bhatia, S., Drabkin, H., Costello, B., Sarantopolous, J., Kanesvaran, R., Lauer, R., Sweeney, C., Hahn, N.M., Sonpavde, G., Richey, S., Breen, T., Kremmidiotis, G., Doolin, E., Bibb
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu337.8
Date:
September, 2014
File:
PDF, 68 KB
2014
Conversion to is in progress
Conversion to is failed